All filters
Slidesets
There is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania - Jason Bacha, Tanzania
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Growth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi - Gabriela Toledo, United Kingdom
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Increased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed - Kim Anderson, South Africa
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Determinants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho - Appolinaire Tiam, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Key Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium - Andrew Edmonds, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Usability and Feasibility of an HIV POC Viral Load to Identify Infants at High Risk of MTCT at Birth in Primary Healthcare Clinics in Mozambique - Bindiya Meggi, Mozambique
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
More Frequent Viral Load Testing, With Point-Of-Care Tests Has No Impact on Viral Suppression in Postpartum HIV-Positive Women in a Randomized Controlled Trial in 2 Clinics in Johannesburg, South Africa - Lee Fairlie, South Africa
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Knowledge and Perceptions of Covid-19 Among Young People Living With HIV in Malawi and the Impact of the Pandemic on Their Health and Wellbeing - Kajal Hirani, Malawi
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Pediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020 - Deborah Carpenter, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
The Impact of COVID-19 on HIV Services for Children Living with HIV Across 14 Countries - Megan Gleason, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Early Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African Countries - Elizabeth Rabold, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Impact of the COVID-19 Pandemic on Perinatal HIV Prevention in Canada: Canadian Perinatal HIV Surveillance Program - Joel Singer, Canada
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Bone Mineral Density/Content of Postpartum Mothers Taking Treatment Including DTG Vs EFV, TDF Vs TAF in Pregnancy and Their Infants: Randomized IMPAACT 2010 Trial - Tapiwa Mbengeranwa, Zimbabwe
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Hypertensive Disorders in Pregnancy and HIV: A Province-Wide Cohort Analysis During 2018 and 2019 in the Western Cape, South Africa - Amy Slogrove, South Africa
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of- Care in the ODYSSEY Trial - Cissy Kityo, Uganda
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa - Claire Davies, South Africa
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial - Hilda Angela Mujuru, Zimbabwe
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Pro (Children Should Be Prioritized) - Marieke van der Zalm, MD, MSc (Clin Epi), PhD
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
LATE BREAKER - Dolutegravir-Based Art is Superior to Standard of Care in Young Children Living With HIV - Pauline Amuge, Uganda
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa - Isaac Ravi Brenner, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 Kg: Preliminary Results from IMPAACT 2019 - Kristina Brooks, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
B/F/Taf in Virologically Suppressed Adolescents and Children: Two- Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers - Eva Natukunda, Uganda
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non- Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial - Alexandra Compagnucci, France
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Progress – and Lack of Progress - on DTG Transition in Children in Africa - Peter Elyanu, MBChB, M.Med, PhD
Presented at:
International Workshop on HIV Pediatrics 2021